Jefferies Group LLC Alx Oncology Holdings Inc Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$62.84 - $87.68 $251,360 - $350,720
-4,000 Closed
0 $0
Q4 2020

Sep 21, 2023
BUY
$34.11 - $112.26 $136,440 - $449,040
4,000 New
4,000 $344,000
Q4 2020

Feb 16, 2021
BUY
$34.11 - $112.26 $136,440 - $449,040
4,000 New
4,000 $345,000

Others Institutions Holding ALXO

# of Institutions
101
Shares Held
39.7M
Call Options Held
134K
Put Options Held
17.4K
View Full List

About ALX ONCOLOGY HOLDINGS INC

ALXO Quotes by TradingView
  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $66M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email